Aspen Pharmacare Holdings Stock Current Valuation
| APN Stock | 17,378 831.00 5.02% |
Valuation analysis of Aspen Pharmacare Holdings helps investors to measure Aspen Pharmacare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Aspen Pharmacare's price fluctuation is very steady at this time. Calculation of the real value of Aspen Pharmacare Holdings is based on 3 months time horizon. Increasing Aspen Pharmacare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aspen stock is determined by what a typical buyer is willing to pay for full or partial control of Aspen Pharmacare Holdings. Since Aspen Pharmacare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aspen Stock. However, Aspen Pharmacare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17378.0 | Real 20915.2 | Hype 17378.0 | Naive 17361.85 |
The real value of Aspen Stock, also known as its intrinsic value, is the underlying worth of Aspen Pharmacare Holdings Company, which is reflected in its stock price. It is based on Aspen Pharmacare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aspen Pharmacare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aspen Pharmacare Holdings helps investors to forecast how Aspen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aspen Pharmacare more accurately as focusing exclusively on Aspen Pharmacare's fundamentals will not take into account other important factors: Aspen Pharmacare Holdings Company Current Valuation Analysis
Aspen Pharmacare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Aspen Pharmacare Current Valuation | 78.78 B |
Most of Aspen Pharmacare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aspen Pharmacare Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Aspen Pharmacare Holdings has a Current Valuation of 78.78 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-Specialty & Generic industry. The current valuation for all South Africa stocks is significantly lower than that of the firm.
Aspen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aspen Pharmacare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aspen Pharmacare could also be used in its relative valuation, which is a method of valuing Aspen Pharmacare by comparing valuation metrics of similar companies.Aspen Pharmacare is currently under evaluation in current valuation category among its peers.
Aspen Fundamentals
| Return On Equity | 0.095 | |||
| Return On Asset | 0.0499 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 78.78 B | |||
| Shares Outstanding | 444.95 M | |||
| Shares Owned By Insiders | 19.32 % | |||
| Shares Owned By Institutions | 60.77 % | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 1.60 X | |||
| Revenue | 38.61 B | |||
| Gross Profit | 18.29 B | |||
| EBITDA | 10.61 B | |||
| Net Income | 8.67 B | |||
| Total Debt | 105 M | |||
| Book Value Per Share | 159.44 X | |||
| Cash Flow From Operations | 5.37 B | |||
| Earnings Per Share | 14.32 X | |||
| Target Price | 175.61 | |||
| Number Of Employees | 8.58 K | |||
| Beta | 0.62 | |||
| Market Capitalization | 98.32 B | |||
| Total Asset | 111.38 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 111.38 B | |||
| Last Dividend Paid | 3.26 |
About Aspen Pharmacare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aspen Pharmacare Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aspen Pharmacare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aspen Pharmacare Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Aspen Stock
Aspen Pharmacare financial ratios help investors to determine whether Aspen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aspen with respect to the benefits of owning Aspen Pharmacare security.